These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28435061)

  • 21. Harnessing the BMP signaling pathway to control the formation of cancer stem cells by effects on epithelial-to-mesenchymal transition.
    Bosukonda A; Carlson WD
    Biochem Soc Trans; 2017 Feb; 45(1):223-228. PubMed ID: 28202676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.
    Li SY; Sun R; Wang HX; Shen S; Liu Y; Du XJ; Zhu YH; Jun W
    J Control Release; 2015 May; 205():7-14. PubMed ID: 25445694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
    Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
    Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cancer therapy targeting cancer stem cell].
    Tsujii M
    Nihon Rinsho; 2014 Jan; 72(1):35-41. PubMed ID: 24597346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer stem cells and drug resistance: the potential of nanomedicine.
    Vinogradov S; Wei X
    Nanomedicine (Lond); 2012 Apr; 7(4):597-615. PubMed ID: 22471722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.
    Zakaria N; Yusoff NM; Zakaria Z; Lim MN; Baharuddin PJ; Fakiruddin KS; Yahaya B
    BMC Cancer; 2015 Feb; 15():84. PubMed ID: 25881239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pien Tze Huang inhibits the proliferation, and induces the apoptosis and differentiation of colorectal cancer stem cells via suppression of the Notch1 pathway.
    Qi F; Wei L; Shen A; Chen Y; Lin J; Chu J; Cai Q; Pan J; Peng J
    Oncol Rep; 2016 Jan; 35(1):511-7. PubMed ID: 26530025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miRNA-regulated delivery of lincRNA-p21 suppresses β-catenin signaling and tumorigenicity of colorectal cancer stem cells.
    Wang J; Lei ZJ; Guo Y; Wang T; Qin ZY; Xiao HL; Fan LL; Chen DF; Bian XW; Liu J; Wang B
    Oncotarget; 2015 Nov; 6(35):37852-70. PubMed ID: 26497997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic strategies targeting cancer stem cells.
    Ning X; Shu J; Du Y; Ben Q; Li Z
    Cancer Biol Ther; 2013 Apr; 14(4):295-303. PubMed ID: 23358473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanomedicine in cancer stem cell therapy: from fringe to forefront.
    Tabassum N; Verma V; Kumar M; Kumar A; Singh B
    Cell Tissue Res; 2018 Dec; 374(3):427-438. PubMed ID: 30302547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.
    Kumar D; Gorain M; Kundu G; Kundu GC
    Mol Cancer; 2017 Jan; 16(1):7. PubMed ID: 28137308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phytonanomedicine: a novel avenue to treat recurrent cancer by targeting cancer stem cells.
    Mohapatra P; Singh P; Sahoo SK
    Drug Discov Today; 2020 Aug; 25(8):1307-1321. PubMed ID: 32554061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Research progression in colorectal cancer stem cells].
    Wu TY; Cui L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):297-300. PubMed ID: 23536355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A nano-based thermotherapy for cancer stem cell-targeted therapy.
    Suo X; Zhang J; Zhang Y; Liang XJ; Zhang J; Liu D
    J Mater Chem B; 2020 May; 8(18):3985-4001. PubMed ID: 32239013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine.
    Kim SS; Harford JB; Pirollo KF; Chang EH
    Biochem Biophys Res Commun; 2015 Dec; 468(3):485-9. PubMed ID: 26116770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delivering cancer stem cell therapies - a role for nanomedicines?
    Schätzlein AG
    Eur J Cancer; 2006 Jun; 42(9):1309-15. PubMed ID: 16682183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The bad seed gardener: Deubiquitinases in the cancer stem-cell signaling network and therapeutic resistance.
    Qiu GZ; Sun W; Jin MZ; Lin J; Lu PG; Jin WL
    Pharmacol Ther; 2017 Apr; 172():127-138. PubMed ID: 27919796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transforming growth factor-beta1 promotes the migration and invasion of sphere-forming stem-like cell subpopulations in esophageal cancer.
    Yue D; Zhang Z; Li J; Chen X; Ping Y; Liu S; Shi X; Li L; Wang L; Huang L; Zhang B; Sun Y; Zhang Y
    Exp Cell Res; 2015 Aug; 336(1):141-9. PubMed ID: 26096658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gain of antitumor functions and induction of differentiation in cancer stem cells contribute to complete cure and no relapse.
    Garg M
    Crit Rev Oncog; 2009; 15(1-2):65-90. PubMed ID: 20136628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Impediments of Cancer Stem Cells and An Exploration into the Nanomedical Solutions for Glioblastoma.
    Jain H; Dhawan P; Rao S; Lalwani N; Shand H
    Anticancer Agents Med Chem; 2023; 23(4):368-382. PubMed ID: 36056850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.